[{"data":1,"prerenderedAt":48},["ShallowReactive",2],{"notifications-general-de":3,"compound-THCV-de":4},"Wegen der Sommerferien arbeitet das Labor vom 22. Juli bis 9. August 2026 nach einem geänderten Zeitplan. Analyseergebnisse sind 7 bis 10 Tage nach Proben­eingang verfügbar. Vielen Dank für Ihr Verständnis.",{"name":5,"shortname":6,"synonyms":7,"cas":8,"molMass":9,"pubchemLink":10,"structure":11,"important":12,"synthetic":13,"compoundClass":14,"asociationImage":17,"summarySet":18,"compoundEffectSet":22},"Tetrahydrocanabivarin","THCV","THV","31262-37-0",286.41,"https:\u002F\u002Fpubchem.ncbi.nlm.nih.gov\u002Fcompound\u002FTetrahydrocannabivarin","science\u002Fstructures\u002FTHCV_sy9Qomq.png",true,false,{"id":15,"description":16},"2","Cannabinoids","",[19],{"summaryText":20,"language":21},"\u003Cp class=\"MsoNormal\">THCV, or tetrahydrocannabivarin, is a compound in cannabis\r\nthat offers a unique array of effects and medical benefits that sets it apart\r\nfrom other cannabinoids like THC and CBD. It is a homologue of\r\ntetrahydrocannabinol (THC) having a propyl (3-carbon) side chain instead of a\r\npentyl (5-carbon) group on the molecule. THCV is a cannabinoid receptor type 1 antagonist and\r\ncannabinoid receptor type 2 partial agonist. Δ8-THCV has also been shown to\r\nbe a CB1 antagonist.\u003Co:p>\u003C\u002Fo:p>\u003C\u002Fp>\u003Cp class=\"MsoNormal\">THCV is an appetite suppressant. THCV may help with diabetes. THCV may reduce panic attacks. It appears to curb anxiety\r\nattacks in PTSD patients without suppressing emotion. THCV may help with Alzheimer’s. THCV stimulates bone growth. \u003C\u002Fp>\u003Cp class=\"MsoNormal\">\u003Co:p>\u003C\u002Fo:p>\u003C\u002Fp>",null,[23,28,32,36,40,44],{"effectName":24,"LiteratureReferences":27},{"effectName":25,"effectType":26},"Anti-acne","A_0","\u003Cp>\u003Ca href=\"http:\u002F\u002Fonlinelibrary.wiley.com\u002Fdoi\u002F10.1111\u002Fexd.13042\u002Ffull\">Differential effectiveness of selected non-psychotropic phytocannabinoids on human sebocyte functions implicates their introduction in dry\u002Fseborrhoeic skin and acne treatment\u003C\u002Fa>\u003Cbr>\u003C\u002Fp>",{"effectName":29,"LiteratureReferences":31},{"effectName":30,"effectType":26},"Anti diabetes and diabetic complications","\u003Cp>\u003Ca href=\"https:\u002F\u002Fwww.ncbi.nlm.nih.gov\u002Fpubmed\u002F?term=27573936\">Efficacy and Safety of Cannabidiol and Tetrahydrocannabivarin on Glycemic and Lipid Parameters in Patients With Type 2 Diabetes: A Randomized, Double-Blind, Placebo-Controlled, Parallel Group Pilot Study\u003C\u002Fa>\u003Cbr>\u003C\u002Fp>",{"effectName":33,"LiteratureReferences":35},{"effectName":34,"effectType":26},"Anticonvulsant - Epilepsy","\u003Cp>\u003Ca href=\"http:\u002F\u002Fonlinelibrary.wiley.com\u002Fdoi\u002F10.1111\u002Fj.1528-1167.2010.02523.x\u002Ffull\">Δ9-Tetrahydrocannabivarin suppresses in vitro epileptiform and in vivo seizure activity in adult rats\u003C\u002Fa>\u003Cbr>\u003C\u002Fp>",{"effectName":37,"LiteratureReferences":39},{"effectName":38,"effectType":26},"Anti inflamation - Ischaemia-reperfusion","\u003Cp>\u003Ca href=\"http:\u002F\u002Fonlinelibrary.wiley.com\u002Fdoi\u002F10.1111\u002Fj.1476-5381.2011.01410.x\u002Ffull\">Δ8-Tetrahydrocannabivarin prevents hepatic ischaemia\u002Freperfusion injury by decreasing oxidative stress and inflammatory responses through cannabinoid CB2 receptors\u003C\u002Fa>\u003Cbr>\u003C\u002Fp>",{"effectName":41,"LiteratureReferences":43},{"effectName":42,"effectType":26},"Antinausea","\u003Cp>\u003Ca href=\"http:\u002F\u002Fonlinelibrary.wiley.com\u002Fdoi\u002F10.1111\u002Fbph.12322\u002Ffull\">Evaluation of the potential of the phytocannabinoids, cannabidivarin (CBDV) and Δ9-tetrahydrocannabivarin (THCV), to produce CB1 receptor inverse agonism symptoms of nausea in rats\u003C\u002Fa>\u003Cbr>\u003C\u002Fp>",{"effectName":45,"LiteratureReferences":47},{"effectName":46,"effectType":26},"Antiobesity","\u003Cp>\u003Ca href=\"https:\u002F\u002Fwww.researchgate.net\u002Fprofile\u002FJimmy_Bell3\u002Fpublication\u002F307442181_Efficacy_and_Safety_of_Cannabidiol_and_Tetrahydrocannabivarin_on_Glycemic_and_Lipid_Parameters_in_Patients_With_Type_2_Diabetes_A_Randomized_Double-Blind_Placebo-Controlled_Parallel_Group_Pilot_Study\u002Flinks\u002F57c96a8a08ae3ac722af75e1.pdf\">Efficacy and Safety of Cannabidiol and Tetrahydrocannabivarin on Glycemic and Lipid Parameters in Patients.\u003C\u002Fa>\u003C\u002Fp>\u003Cp>\u003Ca href=\"http:\u002F\u002Fwww.ncbi.nlm.nih.gov\u002Fpubmed\u002F25542687\">Neural Effects of Cannabinoid CB1 Neutral Antagonist Tetrahydrocannabivarin on Food Reward and Aversion in Healthy Volunteers\u003C\u002Fa>\u003C\u002Fp>\u003Cp>\u003Ca href=\"http:\u002F\u002Fonlinelibrary.wiley.com\u002Fdoi\u002F10.1111\u002Fj.1476-5381.2008.00107.x\u002Ffull\">Synthetic and plant-derived cannabinoid receptor antagonists show hypophagic properties in fasted and non-fasted mice\u003C\u002Fa>\u003C\u002Fp>\u003Cp>\u003Ca href=\"https:\u002F\u002Fwww.researchgate.net\u002Fprofile\u002FJimmy_Bell3\u002Fpublication\u002F307442181_Efficacy_and_Safety_of_Cannabidiol_and_Tetrahydrocannabivarin_on_Glycemic_and_Lipid_Parameters_in_Patients_With_Type_2_Diabetes_A_Randomized_Double-Blind_Placebo-Controlled_Parallel_Group_Pilot_Study\u002Flinks\u002F57c96a8a08ae3ac722af75e1.pdf\">Efficacy and Safety of Cannabidiol and Tetrahydrocannabivarin on Glycemic and Lipid Parameters in Patients\u003C\u002Fa>\u003C\u002Fp>\u003Cp>\u003Ca href=\"https:\u002F\u002Fwww.nature.com\u002Farticles\u002Fnutd20139\">The cannabinoid Δ9-tetrahydrocannabivarin (THCV) ameliorates insulin sensitivity in two mouse models of obesity\u003C\u002Fa>    \u003Cbr>\u003Cbr>\u003Cbr>\u003Cbr>\u003Cbr>\u003C\u002Fp>",1785925845681]